期刊文献+

男性Kallmann综合征的临床诊断与治疗分析 被引量:1

Clinical diagnosis and treatment of male Kallmann syndrome
原文传递
导出
摘要 目的:探讨男性Kallmann综合征的诊断及治疗方法。方法:对12例Kallmann综合征患者的临床资料做回顾性分析。以男性不育就诊者3例,其余9例因第二性征发育不全及外生殖器发育异常就诊。12例均给予人绒毛膜促性腺激素(hCG)、尿促性腺激素(hMG)及十一酸睾酮等治疗6个月~3年。比较12例患者治疗前后第二性征的发育及血清生殖激素变化情况,分析治疗情况。结果:治疗9个月(3个疗程)后12例患者阴茎长度、睾丸体积、生殖激素水平较治疗前均有明显改善,有统计学意义(P〈0.01),第二性征得到不同程度的发育。目前3例已婚者已恢复正常性生活,其中1例患者妻子已正常妊娠。结论:Kallmann综合征的临床特征为促性腺激素缺乏、性腺功能低下、嗅觉缺失或减退,hCG、hMG及雄激素替代治疗是有效的治疗方法。对嗅觉功能障碍暂无有效治疗方法。早期诊断并给予激素替代治疗可最大限度地缓解临床症状并获得生育能力。 Objective: To investigate the diagnosis and treatment of male Kallmann syndrome. Methods: We retrospectively analyzed the clinical data of 12 cases of male Kallmann syndrome, 3 treated for male sterility and the other 9 for secondary sex charac- teristics dysplasia and external genitalia developmental anomalies, all by combined replacement therapy with human chorionic gonado- tropin (hCG), human menopause gonadotropin (hMG) and testosterone undecanoate for 6 months to 3 years. We compared the sec- ondary sexual development and serum sex hormone levels of the patients before and after treatment. Results : After 9 months of treat- ment, all the 12 patients showed significant improvement in the penile length, testicular volume and sex hormone levels (P 〈 0.01 ), with different degrees of promotion of the secondary sexual development. Three married cases could have normal sexual intercourse, and one of them achieved normal pregnancy. Conclusion : The clinical characteristics of Kallmann syndrome include lack of gonadotro- pins, lower gonad function and loss or reduction of olfactory sensation. Replacement therapy with hCG, hMG and androgens is an effec- tive treatment method. However, no effective therapy is now available for olfactory dysfunction. Early diagnosis and hormone replace- ment therapy can best alleviate its clinical symptoms and eventually achieve fertility.
作者 龚炜 高兴成
出处 《中华男科学杂志》 CAS CSCD 2013年第12期1111-1114,共4页 National Journal of Andrology
关键词 KALLMANN综合征 性腺功能低下 嗅觉缺失 基因突变 早期诊断 治疗 Kallmann syndrome hypogonadism anosmia gene mutation early diagnosis treatment
  • 相关文献

参考文献14

  • 1Kaminski BA, Palmert MR. Genetic control of pubertal timing Curt" Opin Pediatr, 2008, 20(4) : 458-464.
  • 2Hardelin JP, Dod6 C. The complex genetics of Kallmann syndrome KAL1, FGFR1, FGF8, PROKR2 PROK2, et al. Sex Dev 2008, 2(4-5) : 181-193.
  • 3Dod6 C, Hardelin JP. Kallmann syndrome. Eur J Hum Genet 2009, 17( 2): 139-146.
  • 4付超,冯征,刘睿智.Kallmann综合征分子遗传学研究进展[J].中华男科学杂志,2011,17(4):361-365. 被引量:5
  • 5Fillion M, Deal CL, Van Vliet G. Normal minipuberty of infancy in boys with Prader-Willi syndrome. J Pediatr, 2006, 149 (6) : 874-876.
  • 6郝丽君,崔英霞,王云华,商学军,黄宇烽.Kallmann综合征的诊断与鉴别诊断[J].中华男科学杂志,2005,11(10):765-766. 被引量:9
  • 7Grumbach MM. A window of opportunity : The diagnosis of gona- dotropin deficiency in the male infant. J Clin Endocrinol Metab, 2005, 90(5) : 3122-3127.
  • 8Lieblich JM, Rogol AD, White BJ, et al. Syndrome of anosmia with hypogonadotropic hypogonadism ( Kallmann syndrome ) : Clinical and laboratory studies in 23 cases. Am J Med, 1982, 73 (e4) : 506-519.
  • 9Miyagawa Y, Tsujimura A, Matsumiya K, et al. Outcome of go_ nadotropin therapy for male hypogonadotropic hypogonadism at university affiliated male infertility centers: A 30-year retrospec- tive study. J Urol, 2005, 173(6) : 2072-2075.
  • 10Btichter D, Behre HM, Kliesch S, et al. Pulsatile GnRH or hu- man chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: A review of 42 cases. Eur J Endocrinol, 1998, 139 (3) : 298- 303.

二级参考文献35

  • 1郝丽君,崔英霞,王云华,商学军,黄宇烽.Kallmann综合征的诊断与鉴别诊断[J].中华男科学杂志,2005,11(10):765-766. 被引量:9
  • 2郝丽君,崔英霞.Kallmann综合征的研究进展[J].中华男科学杂志,2006,12(7):647-649. 被引量:7
  • 3邓春华,梅骅,苗永青.Kallmann 综合征四例报告[J].中华泌尿外科杂志,1997,18(5):298-300. 被引量:13
  • 4Chung WC, Moyle SS, Tsai PS. Fibroblast growth factor 8 signaling through fibroblast growth factor receptor 1 is required for the emergence of gonadotropin-releasing hormone neurons. Endocrinology, 2008 , 149(10) : 4997-5003.
  • 5Trarbach EB, Abreu AP, Silveira LF. Nonsense mutations in FGF8 gene causing different degrees of human gonadotropinreleasing deficiency. J Clin Endocrinol Metab, 2010, 95 (7): 3491-3496.
  • 6Quinton R, Duke VM, Robertson A, et al. Idiopathic gonadotrophin deficiency: Genetic questions addressed through phenotypic characterization. Clin Endocrinol, 2001, 55(2): 163-174.
  • 7Massin N, Pecheux C, Eloit C, et al. X chromosome-linked Kallmann syndrome: Clinical heterogeneity in three siblings carrying an intragenic deletion of the KAL-1 gene. J Clin Endocrinol Metab, 2003, 88(5): 2003-2008.
  • 8Cole LW, Sidis Y, Zhang C, et al. Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: Molecular genetics and clinical spectrum. J Clin Endocrinol Metab, 2008, 93(9) : 3551-3559.
  • 9Pitteloud N, Quinton R, Pearce S, et al. Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism. J Clin Invest, 2007, 117(2) : 457-463.
  • 10Abreu AP, Trarbach EB, de Castro N, et al. Loss-of-function mutations in the genes encoding prokineticin-2 or prokineticin receptor-2 cause autosomal recessive Kallmann syndrome. J Clin Endocrinol Metab, 2008, 93 ( 10 ) : 4113-4118.

共引文献16

同被引文献2

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部